| Jun'18 | Jun'17 | Jun'16 | Jun'15 | ||
|---|---|---|---|---|---|
Revenue | |||||
0 | 0 | - | - | ||
Revenue | |||||
- | - | 0 | - | ||
Research and development expenses | |||||
0 | 0 | 0 | 0 | ||
General and administrative expenses | |||||
0 | 0 | 0 | 0 | ||
Total operating expenses | |||||
0 | 0 | 0 | 0 | ||
Financial expenses (income), net | |||||
0 | 0 | 0 | 0 | ||
Loss before income taxes | |||||
0 | 0 | 0 | 0 | ||
Taxes on Income | |||||
0 | 0 | 0 | 0 | ||
Net loss | |||||
0 | 0 | 0 | 0 | ||
Basic and diluted net loss per share | |||||
0.17 | 0.22 | - | - | ||
Basic and diluted net loss per share from continuing operations (in dollars per share) | |||||
- | - | 0.39 | 0.21 | ||
Weighted-average number of shares outstanding used in computing basic and diluted net loss per share | |||||
15,711 | 12,175 | 11,100 | 11,100 | ||